IGC Pharma
35 hedge funds and large institutions have $1.14M invested in IGC Pharma in 2026 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
16% less capital invested
Capital invested by funds: $1.36M → $1.14M (-$220K)
Holders
35
Holding in Top 10
–
Calls
$1K
Puts
–
Top Buyers
| 1 | +$50.8K | |
| 2 | +$6.45K | |
| 3 | +$6.2K | |
| 4 |
Morgan Stanley
New York
|
+$4.83K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$2.77K |
Top Sellers
| 1 | -$121K | |
| 2 | -$78.1K | |
| 3 | -$8.98K | |
| 4 |
DP
Dearborn Partners
Chicago,
Illinois
|
-$6.94K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.27K |
